Technical and clinical validation of an environmental exposure unit for ragweed

References

• OzdoganogluTSonguMThe burden of allergic rhinitis and asthmaTher Adv Respir Dis201261112322179899
   PubMed Web of Science ®Google Scholar
• BrozekJBousquetJBaena-CagnaniCAllergic rhinitis and its impact on asthma (ARIA) guidelines: 2010 revisionJ Allergy Clin Immunol2010126346647620816182
   PubMed Web of Science ®Google Scholar
• DayJEllisARafeiroERatzJBriscoeMExperimental models for the evaluation of treatment of allergic rhinitisAnn Allergy Asthma Immunol20069626327816498847
   PubMed Web of Science ®Google Scholar
• DayJBriscoMEnvironmental exposure unit: a system to test anti-allergic treatmentAnn Allergy Asthma Immunol199983839310480579
   PubMed Web of Science ®Google Scholar
• HorakFJagerSThe Vienna challenge chamber (VCC) – a new method for allergen exposition testsWein Klin Wocheschr198799509510
   Web of Science ®Google Scholar
• RønborgSMMosbechHJohnsenCRPoulsenLKExposure chamber for allergen challenge. The development and validation of a new conceptAllergy19965182888738512
   PubMed Web of Science ®Google Scholar
• KrugNHohlfeldJLarbigMValidation of an environmental exposure unit for controlled human inhalation studies with grass pollen in patients with seasonal allergic rhinitisClin Exp Allergy2003331667167414656353
   PubMed Web of Science ®Google Scholar
• ZuberbierTAbelsonMBAkdisCAValidation of the GA2LEN chamber for trials in allergy. Innovation of a mobile allergen exposure chamberJ Allergy Clin Immunol Epub9302016
   Google Scholar
• HashiguchiKTangHFujitaTValidation study of the OHIO chamber in patients with Japanese cedar pollinosisInt Arch Allergy Immunol200914914114919127071
   PubMed Web of Science ®Google Scholar
• EnomotoTIdeTOginoSConstruction of an environmental exposure unit and investigation of the effects of cetirizine hydrochloride on symptoms of cedar pollinosis in JapanJ Investig Allergol Clin Immunol200717173181
   PubMed Web of Science ®Google Scholar
• ItoKTeradaTYukiAPreliminary study of a challenge test to the patients with Japanese cedar pollinosis using an environmental exposure unitAuris Nasus Larynx20103769469920452157
   PubMed Web of Science ®Google Scholar
• PatelPD’AndreaCSacksHJOnset of action of azelastine nasal spray compared with mometasone nasal spray and placebo in subjects with seasonal allergic rhinitis evaluated in an environmental exposure chamberAm J Rhinol20072149950317882923
   PubMedGoogle Scholar
• KarshJKellySYangJPerrinsRYangetWClinical evaluation of an allergen Challenge Theatre™Allergy Asthma Clin Immunol201410Suppl 2A21
   Google Scholar
• BerkowitzRBWoodworthGGLutzCOnset of action, efficacy, and safety of fexofenadine 60 mg/pseudoephedrine 120 mg versus placebo in the Atlanta allergen exposure unitAnn Allergy Asthma Immunol2002893845
   PubMed Web of Science ®Google Scholar
• AbelsonMBGomesPLaneKArenasNSigns and symptoms of allergic rhinitis produced by the Allergen BioCube compared to the environment: a validation studyJ Allergy Clin Immunol20111272AB253
   Web of Science ®Google Scholar
• JacobsRLRamirezDAAndrewsCPValidation of the biogenics research chamber for Juniperus ashei (mountain cedar) pollenAnn Allergy Asthma Immunol201110713313821802021
   PubMed Web of Science ®Google Scholar
• EllisANorthMWalkerTSteacyLEnvironmental exposure unit: a sensitive, specific, and reproducible methodology for allergen challengeAnn Allery Asthma Immunol2013111323328
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration (FDA), Center for Drug Evaluation and ResearchGuidance for Industry, Allergic Rhinitis: Clinical Development Programs for Drug Products, Draft GuidanceRockville, MDFDA2000
   Google Scholar
• European Medicines Agency (EMA)Guideline on the Clinical Development of Products for Specific Immunotherapy for the Treatment of Allergic DiseasesLondonEMA2008
   Google Scholar
• US Food and Drug Administration (FDA), Center for Biologics Evaluation and ResearchAllergenic Products Advisory Committee (meeting)May 12, 2011 Unedited transcript150
   Google Scholar
• Rosner-FrieseKKaulSViethsSPfaarOEnvironmental exposure chambers in allergen immunotherapy trials: current status and clinical validation needsJ Allergy Clin Immunol2014135363664325528360
   PubMed Web of Science ®Google Scholar
• NorthMSolimanMWalkerTSteacyLEllisAControlled allergen challenge facilities and their unique contributions to allergic rhinitis researchCurr Allergy Asthma Rep2015151126130471
   PubMed Web of Science ®Google Scholar
• ZieglmayerPAre results of environmental exposure units transferable to real-life exposure?Curr Opin Allergy Clin Immunol20131324424823549153
   PubMed Web of Science ®Google Scholar
• BernsteinJCorrelation between a pollen challenge chamber and a natural allergen exposure study design for eliciting ocular and nasal symptoms: early evidence supporting a paradigm shift in drug investigation?J Allergy Clin Immunol201213012812922742840
   PubMed Web of Science ®Google Scholar
• LaneKGomesPAngjeliEEllisAUniformed distribution of aerosolized dust mite allergen in the Allergen BioCube (ABC)J Allergy Clin Immunol20141332AB189
   Web of Science ®Google Scholar
• AngjeliELaneKSchoemmellERavalYGomesPValidation and verification of grass allergen challenge in the Allergen BioCube® (ABC)J Allergy Clin Immunol20161372 SupplAB262
   Web of Science ®Google Scholar
• ViirreEVillafrancaJEMillerSDGomesPLasserEContrast agent reduces allergic rhinitis symptomsJ Allergy Clin Immunol20161372AB857
   Web of Science ®Google Scholar
• TogiasAEnvironmental exposure units: clinical trial design for validationBethesda, MDNational Institute for Allergy and Infectious Diseases/National Institutes of Health2010112
   Google Scholar